E
Y-mAbs Therapeutics, Inc. YMAB
$11.75 -$0.16-1.34%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.93
Price History YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -4.55%
30-Day Total Return -31.49%
60-Day Total Return -30.64%
90-Day Total Return -9.96%
Year to Date Total Return 71.03%
1-Year Total Return 46.69%
2-Year Total Return 1.64%
3-Year Total Return -66.02%
5-Year Total Return -43.46%
52-Week High % Change -43.01%
52-Week Low % Change 158.91%
Price YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $20.90
52-Week Low Price $4.60
52-Week Low Price (Date) Aug 14, 2023
52-Week High Price (Date) Mar 01, 2024
Valuation YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 522.64M
Enterprise Value 448.07M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.50
Earnings Per Share Growth -70.73%
Price/Earnings To Growth --
Price/Sales (TTM) 6.17
Price/Book (Q) 5.27
Enterprise Value/Revenue (TTM) 5.30
Price $11.75
Enterprise Value/EBITDA (TTM) -18.39
Enterprise Value/EBIT -17.87
Market Cap Category Small Cap
Dividends and Shares YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 43.78M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 646 885 8505
Address 230 Park Avenue New York, NY 10169
Website www.ymabs.com
Country United States
Year Founded 2015
Profitability YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -29.67%
Profit Margin -25.64%
Management Effectiveness YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -12.02%
Return on Equity --
Income Statement YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 84.50M
Total Revenue (TTM) 84.50M
Revenue Per Share $1.93
Gross Profit (TTM) 73.02M
EBITDA (TTM) -24.37M
EBIT (TTM) -25.08M
Net Income (TTM) -21.67M
Net Income Avl. to Common (TTM) -21.67M
Total Revenue Growth (Q YOY) -1.58%
Earnings Growth (Q YOY) -3.74%
EPS Diluted (TTM) -0.50
EPS Diluted Growth (Q YOY) -0.93%
Balance Sheet YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 75.75M
Cash Per Share (Q) $1.73
Total Current Assets (Q) 108.27M
Total Preferred Equity (Q) --
Total Equity (Q) 99.19M
Current Ratio (Q) 6.150
Book Value Per Share (Q) $2.26
Total Assets (Q) 123.32M
Total Current Liabilities (Q) 17.61M
Total Debt (Q) 1.18M
Total Liabilities (Q) 24.13M
Total Common Equity (Q) 99.19M
Cash Flow YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 688.00K
Net Change in Cash (TTM) -16.88M
Levered Free Cash Flow (TTM) -17.84M
Cash from Operations (TTM) -17.59M
Weiss Ratings